Citations

Showing 10 of 108094 citations.

Deep Brain Stimulation of Anterior Nuclei of the Thalamus and Hippocampal Seizure Rate Modulate Verbal Memory Performance
Richner, Tom J., Sladky, Vladimir , Marks, Victoria S. , Richner, Tom J., Gregg, Nicholas M. , Doležal, Jaromír , Křemen, Václav , Worrell, Gregory A. , Kucewicz, Michał T.

Mayo Clinic

2022 IEEE International Conference on Electro Information Technology (eIT) | July 7, 2022 | Volume: No volume available | Issue: No issue available | Pages: 1-4

10.1109/eit53891.2022.9813930 Get It

Race, rituximab, and relapse in TTP
Antun, Ana G., Farland, Andrew M., Metjian, Ara , Park, Yara A. , Ridder, Gustaaf de, Gibson, Briana, Kasthuri, Raj S. , Akwaa, Frank, Clover, Todd, Upreti, Harsh Vardhan , Liu, Angela , Gangaraju, Radhika , Zheng, X. Long , Masias, Camila , Johnson, Andrew D. , Davis, Elizabeth E. , Evans, Michael D. , Mazepa, Marshall , Metjian, Ara , Kasthuri, Raj S , Baumann Kreuziger, Lisa , Sridharan, Meera , McCrae, Keith R , Lim, Ming Y , Zheng, X Long , Raval, Jay S , Evans, Michael D , Mazepa, Marshall A , Chaturvedi, Shruti , Woods, Ryan, Liles, Darla , Kreuziger, Lisa Baumann , Sadler, J. Evan , Sridharan, Meera , Go, Ronald S. , McCrae, Keith R. , Raval, Jay S. , Cataland, Spero R. , Davis, Elizabeth

Mayo Clinic

Blood | July 7, 2022 | Volume: 140 | Issue: 12 | Pages: 1335-1344

10.1182/blood.2022016640 | PMID 35797471 Get It

Abstract Immune-mediated thrombotic thrombocytopenic purpura (iTTP) is characterized by recurring episodes of thrombotic microangiopathy, causing ischemic organ impairment. Black patients are overrepresented in iTTP cohorts in the United States, but racial disparities in iTTP outcome and response to therapy have not been studied. Using the United States Thrombotic Microangiopathies Consortium iTTP Registry, we evaluated the impact of race on mortality and relapse-free survival (RFS) in confirmed iTTP in the United States from 1995 to 2020. We separately examined the impact of rituximab therapy and presentation with newly diagnosed (de novo) or relapsed iTTP on RFS by race. A total of 645 participants with 1308 iTTP episodes were available for analysis. Acute iTTP mortality did not differ by race. When all episodes of iTTP were included, Black race was associated with shorter RFS (hazard ratio [HR], 1.60; 95% CI, 1.16-2.21); the addition of rituximab to corticosteroids improved RFS in White (HR, 0.37; 95% CI, 0.18-0.73) but not Black patients (HR, 0.96; 95% CI, 0.71-1.31). In de novo iTTP, rituximab delayed relapse, but Black patients had shorter RFS than White patients, regardless of treatment. In relapsed iTTP, rituximab significantly improved RFS in White but not Black patients. Race affects overall relapse risk and response to rituximab in iTTP. Black patients may require closer monitoring, earlier retreatment, and alternative immunosuppression after rituximab treatment. How race, racism, and social determinants of health contribute to the disparity in relapse risk in iTTP deserves further study.
Levels of secretory leukocyte protease inhibitor expression in acute wounds
Lai, Jengyu, Basford, Jeffrey R. , Pittelkow, Mark R.

Mayo Clinic

Journal of Wound Care | July 7, 2022 | Volume: 31 | Issue: Sup7 | Pages: S15-S19

10.12968/jowc.2022.31.sup7.s15 | PMID 35797252 Get It

Objective: Even with our best practices, we are frequently unable to prevent slow and stalled wound healing—particularly in people with impaired circulation and conditions such as diabetes. As a result, greater insight into the nature of wound healing and alternative treatment approaches is needed. An avenue that may be of particular promise is increasing understanding of the role of secretory leukocyte protease inhibitor (SLPI) as there is evidence that it enhances wound healing, its expression increases in response to inflammation and infection, and it exhibits anti-protease, anti-inflammatory, antiviral antibacterial and antifungal activities. Method: The response of SLPI levels to wounding and skin injury was assessed by taking punch skin biopsies from healthy volunteers and assessing the levels of SLPI at the site of injury at the time of wounding (baseline) as well as one, two, three, four, seven, nine and 12 weeks later. Results: A total of 35 volunteers took part in the study. Significant elevations were found: levels of SLPI were greatly increased, 12 times that at baseline, and remained elevated at three weeks despite re-epithelialisation having occurred. Conclusion: These findings not only suggest that levels of SLPI rise rapidly following wounding, but that these elevations are sustained, and continue to increase even when re-epithelialisation has occurred. These results suggest that the role and potential benefits of this protease inhibitor deserve further exploration.
STOPS
Lund, Sarah , Woerster, Malin, Sawatsky, Adam P. , Dozois, Eric J. , D’Angelo, Anne-Lise D. , D'Angelo, Jonathan D, Kelley, Scott R. , D'Angelo, Anne-Lise D, D’Angelo, Jonathan D.

Mayo Clinic

Annals of Surgery | July 7, 2022 | Volume: 276 | Issue: 2 | Pages: 288-292

10.1097/sla.0000000000005447 | PMID 35797637 Get It

Objective: To investigate the steps faculty surgeons take upon experiencing intraoperative error and synthesize these actions to offer a framework for coping with errors. Background: While intraoperative errors are inevitable, formal training in error recovery is insufficient and there are no established curricula that teach surgeons how to deal with the intraoperative error. This is problematic because insufficient error recovery is detrimental to both patient outcomes and surgeon psychological well-being. Methods: We conducted a thematic analysis. One-hour in-depth semistructured interviews were conducted with faculty surgeons from 3 hospitals. Surgeons described recent experiences with intraoperative error. Interviews were transcribed and coded. Analysis allowed for development of themes regarding responses to errors and coping strategies. Results: Twenty-seven surgeons (30% female) participated. Upon completion of the analysis, themes emerged in 3 distinct areas: (1) Exigency, or a need for training surgical learners how to cope with intraoperative errors, (2) Learning, or how faculty surgeons themselves learned to cope with intraoperative errors, and (3) Responses, or how surgeons now handle intraoperative errors. The latter category was organized into the STOPS framework: Intraoperative errors could produce STOPS: Stop, Talk to your Team, Obtain Help, Plan, Succeed. Conclusions and Relevance: This study provides both novel insight into how surgeons cope with intraoperative errors and a framework that may be of great use to trainees and faculty alike.
Assessing Digital Mental Health Apps: The Importance of Patient-Centric Measures of Utility
Stroud, Austin M. , Richardson, Jordan , Sharp, Richard R , Richardson, Jordan P , Sharp, Richard R.

Mayo Clinic

AJOB Neuroscience | July 7, 2022 | Volume: 13 | Issue: 3 | Pages: 209-211

10.1080/21507740.2022.2082591 | PMID 35797116 Get It

Adenosine A 2A receptor blockade prevents cisplatin-induced impairments in neurogenesis and cognitive function
Oliveros, Alfredo , Yoo, Ki Hyun , Rashid, Mohammad Abdur , Corujo-Ramirez, Ana , Hur, Benjamin, Sung, Jaeyun , Liu, Yuanhang , Hawse, John R. , Jang, Mi‐Hyeon , Sung, Jaeyun , Choi, Doo‐Sup , Boison, Detlev

Mayo Clinic

Proceedings of the National Academy of Sciences | July 7, 2022 | Volume: 119 | Issue: 28 | Pages: No page available

10.1073/pnas.2206415119 | PMID 35867768 Get It

Chemotherapy-induced cognitive impairment (CICI) has emerged as a significant medical problem without therapeutic options. Using the platinum-based chemotherapy cisplatin to model CICI, we revealed robust elevations in the adenosine A 2A receptor (A 2A R) and its downstream effectors, cAMP and CREB, by cisplatin in the adult mouse hippocampus, a critical brain structure for learning and memory. Notably, A 2A R inhibition by the Food and Drug Administration–approved A 2A R antagonist KW-6002 prevented cisplatin-induced impairments in neural progenitor proliferation and dendrite morphogenesis of adult-born neurons, while improving memory and anxiety-like behavior, without affecting tumor growth or cisplatin’s antitumor activity. Collectively, our study identifies A 2A R signaling as a key pathway that can be therapeutically targeted to prevent cisplatin-induced cognitive impairments.
Risk factors for breast cancer–related lymphedema in patients undergoing 3 years of prospective surveillance with intervention
Koelmeyer, Louise , Gaitatzis, Katrina , Dietrich, Mary S. , Shah, Chirag , Boyages, John , McLaughlin, Sarah A. , Taback, Bret , Stolldorf, Deonni P. , Hughes, Michael , French, James , Ngui, Nicholas , Hsu, Jeremy , Moore, Andrew , Ridner, Sheila H. , Koelmeyer, Louise A , Shah, Chirag S , Ridner, Sheila H , Elder, Elisabeth Edström , Moore, Andrew

Mayo Clinic

Cancer | July 7, 2022 | Volume: 128 | Issue: 18 | Pages: 3408-3415

10.1002/cncr.34377 | PMID 35797441 Get It

BackgroundTo evaluate risk factors (treatment‐related, comorbidities, and lifestyle) for breast cancer–related lymphedema (BCRL) within the context of a Prospective Surveillance and Early Intervention (PSEI) model of care for subclinical BCRL.MethodsThe parent randomized clinical trial assigned patients newly diagnosed with breast cancer to PSEI with either bioimpedance spectroscopy (BIS) or tape measurement (TM). Surgical, systemic and radiation treatments, comorbidities, and lifestyle factors were recorded. Detection of subclinical BCRL (change from baseline of either BIS L‐Dex ≥6.5 or tape volume ≥ 5% and < 10%) triggered an intervention with compression therapy. Volume change from baseline ≥10% indicated progression to chronic lymphedema and need for complex decongestive physiotherapy. In this secondary analysis, multinomial logistic regressions including main and interaction effects of the study group and risk factors were used to test for factor associations with outcomes (no lymphedema, subclinical lymphedema, progression to chronic lymphedema after intervention, progression to chronic lymphedema without intervention). Post hoc tests of significant interaction effects were conducted using Bonferroni‐corrected alphas of .008; otherwise, an alpha of .05 was used for statistical significance.ResultsThe sample (n = 918; TM = 457; BIS = 461) was female with a median age of 58.4 years. Factors associated with BCRL risk included axillary lymph node dissection (ALND) (p < .001), taxane‐based chemotherapy (p < .001), regional nodal irradiation (RNI) (p ≤ .001), body mass index >30 (p = .002), and rurality (p = .037). Mastectomy, age, hypertension, diabetes, seroma, smoking, and air travel were not associated with BCRL risk.ConclusionsWithin the context of 3 years of PSEI for subclinical lymphedema, variables of ALND, taxane‐based chemotherapy, RNI, body mass index >30, and rurality increased risk.
Multifidus Sarcopenia Is Associated With Worse Patient-reported Outcomes Following Posterior Cervical Decompression and Fusion
Townsley, Sarah, Omar, Adan, Freedman, Brett A. , Currier, Bradford L. , Elder, Benjamin D. , Bydon, Mohamad , Wagner, Scott C. , Sebastian, Arjun S. , Pinter, Zachariah W. , Salmons, Harold I. , Nassr, Ahmad

Mayo Clinic

Spine | July 7, 2022 | Volume: 47 | Issue: 20 | Pages: 1426-1434

10.1097/brs.0000000000004386 | PMID 35797647 Get It

Study Design. Retrospective cohort study. Objective. The present study is the first to assess the impact of paraspinal sarcopenia on patient-reported outcome measures (PROMs) following posterior cervical decompression and fusion (PCDF). Summary of Background Data. While the impact of sarcopenia on PROMs following lumbar spine surgery is well-established, the impact of sarcopenia on PROMs following PCDF has not been investigated. Materials and Methods. We performed a retrospective review of patients undergoing PCDF from C2 to T2 at a single institution between the years 2017 and 2020. Two independent reviewers who were blinded to the clinical outcome scores utilized axial cuts of T2-weighted magnetic resonance imaging sequences to assess fatty infiltration of the bilateral multifidus muscles at the C5–C6 level and classify patients according to the Fuchs Modification of the Goutalier grading system. PROMs were then compared between subgroups. Results. We identified 99 patients for inclusion in this study, including 28 patients with mild sarcopenia, 45 patients with moderate sarcopenia, and 26 patients with severe sarcopenia. There was no difference in any preoperative PROM between the subgroups. Mean postoperative Neck Disability Index scores were lower in the mild and moderate sarcopenia subgroups (12.8 and 13.4, respectively) than in the severe sarcopenia subgroup (21.0, P <0.001). A higher percentage of patients with severe multifidus sarcopenia reported postoperative worsening of their Neck Disability Index (10 patients, 38.5%; P =0.003), Visual Analog Scale Neck scores (7 patients, 26.9%; P =0.02), Patient-Reported Outcome Measurement Information System Physical Component Scores (10 patients, 38.5%; P =0.02), and Patient-Reported Outcome Measurement Information System Mental Component Scores (14 patients, 53.8%; P =0.02). Conclusion. Patients with more severe paraspinal sarcopenia demonstrate less improvement in neck disability and physical function postoperatively and are substantially more likely to report worsening PROMs postoperatively. Level of Evidence. 3.
SARS-CoV-2 infection produces chronic pulmonary epithelial and immune cell dysfunction with fibrosis in mice
Dinnon, Kenneth H. , Leist, Sarah R. , Dang, Hong , Fritch, Ethan J. , Gully, Kendra L. , Cruz, Gabriela De la , Evangelista, Mia D. , Asakura, Takanori , Gilmore, Rodney C. , Hawkins, Padraig, Nakano, Satoko , West, Ande , Schäfer, Alexandra, Gralinski, Lisa E. , Zweigart, Mark R. , Dong, Stephanie , McBride, Jennifer , Cooley, Michelle R. , Hines, Jesse B., Love, Miriya K., Groshong, Steve D. , VanSchoiack, Alison , Phelan, Stefan, Liang, Yan , Hether, Tyler , Zumwalt, Ross E., Barton, Lisa M., Duval, Eric J., Stroberg, Edana , Borczuk, Alain , Thorne, Leigh B., Sakthivel, Muthu , Lee, Yueh Z. , Mock, Jason R. , Seibold, Max A. , O’Neal, Wanda K. , Montgomery, Stephanie A. , Boucher, Richard C. , Okuda, Kenichi , Dang, Hong , Fritch, Ethan J , Gully, Kendra L , De la Cruz, Gabriela , Evangelista, Mia D , Asakura, Takanori , Gilmore, Rodney C , Nakano, Satoko , West, Ande , Schäfer, Alexandra , Gralinski, Lisa E , Everman, Jamie L , Sajuthi, Satria P , Dong, Stephanie , McBride, Jennifer , Cooley, Michelle R , Groshong, Steve D , VanSchoiack, Alison , Phelan, Stefan J , Liang, Yan , Hether, Tyler , Leon, Michael , Sakthivel, Muthu K , Lee, Yueh Z , Hagood, James S , Mock, Jason R , Seibold, Max A , O'Neal, Wanda K , Montgomery, Stephanie A , Boucher, Richard C , Baric, Ralph S , Mukhopadhyay, Sanjay

Mayo Clinic

Science Translational Medicine | July 7, 2022 | Volume: 14 | Issue: 664 | Pages: No page available

10.1126/scitranslmed.abo5070 | PMID 35857635 Get It

A subset of individuals who recover from coronavirus disease 2019 (COVID-19) develop post-acute sequelae of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (PASC), but the mechanistic basis of PASC-associated lung abnormalities suffers from a lack of longitudinal tissue samples. The mouse-adapted SARS-CoV-2 strain MA10 produces an acute respiratory distress syndrome in mice similar to humans. To investigate PASC pathogenesis, studies of MA10-infected mice were extended from acute to clinical recovery phases. At 15 to 120 days after virus clearance, pulmonary histologic findings included subpleural lesions composed of collagen, proliferative fibroblasts, and chronic inflammation, including tertiary lymphoid structures. Longitudinal spatial transcriptional profiling identified global reparative and fibrotic pathways dysregulated in diseased regions, similar to human COVID-19. Populations of alveolar intermediate cells, coupled with focal up-regulation of profibrotic markers, were identified in persistently diseased regions. Early intervention with antiviral EIDD-2801 reduced chronic disease, and early antifibrotic agent (nintedanib) intervention modified early disease severity. This murine model provides opportunities to identify pathways associated with persistent SARS-CoV-2 pulmonary disease and test countermeasures to ameliorate PASC.